跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AMOXYCLAV DUO SCP 500/125 amoxicillin (as trihydrate) 500mg and clavulanic acid (as potassium clavulanate) 125mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
AMOXYCLAV DUO SCP 500/125 amoxicillin (as trihydrate) 500mg and clavulanic acid (as potassium clavulanate) 125mg tablet blister pack
Approved
STANDARD
AMOXYCLAV DUO SCP 500/125 amoxicillin (as trihydrate) 500mg and clavulanic acid (as potassium clavulanate) 125mg tablet blister pack
Southern Cross Pharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
2585ec8e946e81e0
Company
Southern Cross Pharma Pty Ltd
Type
Standard
Approval Details
Approval Id
2585ec8e946e81e0
Product Name
AMOXYCLAV DUO SCP 500/125 amoxicillin (as trihydrate) 500mg and clavulanic acid (as potassium clavulanate) 125mg tablet blister pack
Artg Id
231940
Artg Name
AMOXYCLAV DUO SCP 500/125 amoxicillin (as trihydrate) 500mg and clavulanic acid (as potassium clavulanate) 125mg tablet blister pack
Sponsor
Southern Cross Pharma Pty Ltd
Company Detail Path
/organization/southern-cross-pharma-pty-ltd
Artg Date
2016-07-12
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
2585ec8e946e81e0
Type
Standard
Back to TGA Approvals